Johnson & Johnson (JNJ) Tops Q3 EPS by 3c; Boosts FY11 Outlook
October 18, 2011 7:46 AM
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $1.24, $0.03 better than the analyst estimate of $1.21. Revenue for the quarter came in at $16 billion versus the consensus estimate of $16.02 billion.
Johnson & Johnson sees FY2011 EPS of $4.95-$5.00, versus the consensus of $4.96. The company had previously guided to $4.90-$5.
